Flavoxate (Urispas)
39
relevant articles (4 outcomes,
8 trials/studies)
found for this Drug
Description:
A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist.
Also Known As:
Urispas; Bladuril; Byk Brand of Flavoxate Hydrochloride; Cahill May Roberts Brand of Flavoxate Hydrochloride; Flavoxate Hydrochloride; Hoechst Brand of Flavoxate Hydrochloride; Negma Brand of Flavoxate Hydrochloride; Ortho Brand of Flavoxate Hydrochloride; Pierre Fabre Brand of Flavoxate Hydrochloride; Recordati Brand of Flavoxate Hydrochloride; Shire Brand of Flavoxate Hydrochloride; Spasuret; Uronid; Hydrochloride, Flavoxate; 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester
Relationship Network
Drug Context: Research Results
Experts
Related Diseases
| 1. | Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
|
| 2. | Urinary Incontinence
|
| 3. | Abnormal Reflex (Hyperreflexia)
|
| 4. | Erectile Dysfunction
12/01/2008
- " To assess the safety and efficacy of combination therapies for LUTS associated with BPH, a search of the MEDLINE and Cochrane databases (1976-2008) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia, lower urinary tract symptoms, alpha(1)-adrenergic receptor antagonists, 5alpha-reductase inhibitors, anti-muscarinics, anticholinergics, combination therapy, alfuzosin, doxazosin, tamsulosin, terazosin, dutasteride, finasteride, tolterodine, flavoxate, propiverine, oxybutynin, erectile dysfunction, sildenafil, vardenafil and tadalafil"
Get all the results and reference details, order at left...
|
| 5. | Nocturia
03/01/2008
- " Supplemental administration of flavoxate hydrochloride is therefore effective for the improvement of nocturia and QOL in BPH patients resistant to an alpha1-adrenoceptor blocker." 03/01/2008
- " We examined the effectiveness of supplemental administration of flavoxate hydrochloride in patients with benign prostatic hyperplasia (BPH) whose nocturia was not adequately relieved by an alpha1-adrenoceptor blocker" 03/01/2008
- " Clinical evaluation of supplemental administration of flavoxate hydrochloride in benign prostatic hyperplasia patients with nocturia resistant to an alpha1-adrenoceptor blocker]" 01/01/1986
- " Forty patients, aged 51 to 79 years, with nocturia due to bladder instability, resorption of postural edema, or senile decay, were treated with rociverine or flavoxate to test the possibility of reducing or eliminating nocturnal voidings" 01/01/1986
- " Forty inpatient men and women, between 50 and 80 years of age, with nocturia due to bladder instability, resorption of postural edema, or senile involution were admitted to a clinical trial designed to test the possibility of reducing or eliminating nocturnal voidings by means of a single evening dose of rociverine or flavoxate"
Get all the results and reference details, order at left...
|
| 25 Diseases
and
39
more articles analyzed in the Research Interface, order at left...
|
Related Drugs and Biologics
Related Therapies and Procedures